The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Pediatric Thalassemia Major — Splenectomy

Surgical removal of the spleen in transfusion-dependent beta-thalassemia children to reduce hypersplenism and transfusion needs.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Çocuk Sağlığı ve Hastalıkları department. Book Appointment →

What is Pediatric Thalassemia Major — Splenectomy?

Splenectomy in pediatric beta-thalassemia major is a surgical option reserved for selected patients with progressive hypersplenism, defined by an annual transfusion requirement greater than 200 to 220 mL/kg of packed red cells despite optimized chelation, marked splenomegaly with mechanical symptoms, or hypersplenic cytopenias.

The procedure should ideally be deferred beyond 5 to 7 years of age to minimize lifetime risk of overwhelming post-splenectomy infection (OPSI), and increasingly partial or laparoscopic splenectomy is preferred over total splenectomy.

Preoperative preparation includes vaccination at least two weeks before surgery against encapsulated organisms (pneumococcus 13- and 23-valent, meningococcus B and ACWY, Haemophilus influenzae type b), influenza vaccine, education on febrile illness, and optimization of iron chelation.

Postoperative complications include OPSI, portal vein thrombosis (especially with very high platelet counts), arterial and pulmonary thromboembolism, and accelerated extramedullary hematopoiesis with paraspinal masses.

Lifelong management requires daily oral antibiotic prophylaxis (penicillin V or amoxicillin) through adolescence, prompt empirical antibiotics for any febrile illness, annual booster vaccinations as indicated, antithrombotic prophylaxis in selected patients and continued chelation.

Symptoms

Increasing red cell transfusion requirements
Growing splenomegaly with abdominal discomfort
Early satiety and reduced food intake from spleen size
Worsening anemia and fatigue between transfusions
Leukopenia or thrombocytopenia from hypersplenism
Infections with encapsulated bacteria after surgery
Persistent low-grade fever and rising platelet count post-op (thrombosis risk)

Risk Factors

Transfusion-dependent beta-thalassemia major
Progressive hypersplenism with increasing transfusion needs
Mechanical complications from massive splenomegaly
Thrombocytopenia and leukopenia from sequestration
Inadequate iron chelation tolerance

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Rising transfusion frequency in known thalassemia patient
  • Massively enlarged spleen causing abdominal symptoms
  • Any fever in a splenectomized patient
  • Severe abdominal pain after splenectomy (suspect portal thrombosis)
  • Persistent fatigue and growth failure despite transfusions

Treatment Methods

01
Comprehensive preoperative vaccination at least two weeks before surgery
02
Laparoscopic total or partial splenectomy in experienced center
03
Postoperative thromboprophylaxis with low molecular weight heparin and aspirin if platelet count rises
04
Lifelong antibiotic prophylaxis (penicillin V or amoxicillin) at least until adolescence
05
Emergency stand-by antibiotics for any fever
06
Annual immunization review (pneumococcal, meningococcal, influenza)
07
Continued iron chelation with deferasirox, deferiprone or deferoxamine
08
Long-term hematology and hepatology follow-up
09
Discussion of curative options (allogeneic stem cell transplant, gene therapy)

Which Department to Visit?

You can visit our Çocuk Sağlığı ve Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Çocuk Sağlığı ve Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Newborn Care

Çocuk Sağlığı ve Hastalıkları

The newborn period is a critical phase that requires attentive care of the umbilical stump, temperature regulation, feeding, monitoring of jaundice and screening tests.

Vaccination Schedule

Çocuk Sağlığı ve Hastalıkları

The Turkish Ministry of Health national vaccination schedule arranges the immunization program from birth to adulthood. Timely and complete vaccination is critical in protecting community immunity.

Jaundice in Infants

Çocuk Sağlığı ve Hastalıkları

Neonatal jaundice (jaundice in newborns) presents as yellowing of the skin and eyes. The vast majority of cases are physiological and are easily treated with phototherapy.

Diarrhoea in Infants

Çocuk Sağlığı ve Hastalıkları

Acute diarrhoea is defined as 3 or more loose stools per day. In infants it is most often caused by viral gastroenteritis (rotavirus, norovirus); dehydration may lead to serious complications.

Fever Management in Children

Çocuk Sağlığı ve Hastalıkları

Fever in children (38°C and above) is the body's defense mechanism against viral or bacterial infection. Most fevers resolve spontaneously in 3-5 days; however, some conditions require urgent medical evaluation.

Cough in Children

Çocuk Sağlığı ve Hastalıkları

Cough is the most common symptom in children and is mostly due to viral upper respiratory infections. Cough lasting more than 3 weeks or with characteristic sounds requires detailed evaluation.

Bronchiolitis

Çocuk Sağlığı ve Hastalıkları

Supportive care with hydration, nasal suctioning, and oxygen if hypoxic is the mainstay; routine bronchodilators, corticosteroids, and antibiotics are not recommended per AAP/NICE guidelines.

Croup (Laryngotracheobronchitis)

Çocuk Sağlığı ve Hastalıkları

Croup is a viral inflammation of the larynx and trachea presenting with a barking cough, hoarseness, and inspiratory stridor. It mostly affects children aged 6 months to 3 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.